ILÚM Health Solutions to Present Data from the Hospital of the University of Pennsylvania on Implementation of an Electronic Antimicrobial Prior Authorization Approval Process at ID Week 2018
KENILWORTH, N.J.--(BUSINESS WIRE)--Oct 1, 2018--ILÚM Health Solutions, a provider of technology and services to support infectious disease management, today announced that data demonstrating the implementation and evaluation of its electronic antimicrobial prior authorization (PA) approval process at the Hospital of the University of Pennsylvania, will be presented at ID Week 2018, to be held October 3-7 in San Francisco.
Prior authorization of antimicrobial agents is recommended by the CDC as a broad antimicrobial stewardship (AMS) intervention and has been a cornerstone of the Hospital of the University of Pennsylvania (HUP) AMS program since its inception. Hospitals utilizing prior authorization require providers to obtain approval from the AMS team prior to prescribing specific restricted antimicrobials. The PA approval process may reduce initiation of inappropriate or unnecessary antimicrobial agents while also serving to educate providers at prime decision-making moments and inform future treatment choices; however, securing AMS team approval can be a cumbersome process that can delay appropriate treatment.
“Effectively managing patients with infectious diseases requires rapidly getting the right information to the right people to optimize decision-making,” said Brandon Palermo, MD, ILÚM chief medical officer. “We look forward to sharing data that demonstrates how ILÚM’s technologies can transform critical use processes, support antibiotic stewardship at the point-of-care, enable efficiencies in terms of time, and most importantly, improve the quality of care provided to patients.”
“Calling the ID approval pager, waiting for a callback, discussing the case with the AMS team, and receiving approval or an alternative recommendation can be a challenging process and for a very ill patient requires time that he or she may not have,” said Jimish M. Mehta, PharmD, ILÚM vice president of product. “For the first time, we have baseline data that provides insight into how a big university system integrated and enthusiastically adopted an electronic PA system. “
Presentations by ILÚM Health Solutions and its collaborators will take place as follows:
Title: Implementation and Evaluation of an Electronic Antimicrobial Prior Authorization Approval Process at a Large Academic Medical Center Date and Time: Thursday, October 4, 2018 12:30-1:45 pm Location: Room: S Poster Hall Poster Presentation: 184 Session: Antimicrobial Stewardship: Interventions Leveraging the Electronic Health Record
Title: Clinical Impact of Real-Time Predictive Model to Facilitate Antibiotic Prescribing in Gram-Negative Bacteremia Date and Time: Saturday, October 6, 2018 12:30-1:45 pm Location: Room: S Poster Hall Poster Presentation: 1800 Session: Antimicrobial Stewardship: Impact of New Diagnostics
Title: External Validation of Precision Antibiotic Therapy for Enterococcal Bloodstream Infections Date and Time: Saturday, October 6, 2018: 12:30 PM-1:45 PM Location: Room: S Poster Hall Poster Presentation: 1814 Session: Antimicrobial Stewardship: New Methods and Metrics
ILÚM Health Solutions is a provider of technology and services to support infectious disease management. ILÚM is part of Healthcare Services & Solutions, LLC, a wholly-owned subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA (known as MSD outside the United States and Canada), an independent business unit focused on improving the value of care delivered to patients through evidence-based services and solutions. For more information, visit www.ILÚMhealthsolutions.com and connect with us on Twitter and LinkedIn.
View source version on businesswire.com:https://www.businesswire.com/news/home/20181001005103/en/
CONTACT: ILÚM Health Solutions
Molly Watson, 413-454-3926
KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA NEW JERSEY PENNSYLVANIA
INDUSTRY KEYWORD: TECHNOLOGY DATA MANAGEMENT SOFTWARE HEALTH HOSPITALS INFECTIOUS DISEASES MOBILE/WIRELESS
SOURCE: ILÚM Health Solutions
Copyright Business Wire 2018.
PUB: 10/01/2018 08:00 AM/DISC: 10/01/2018 08:01 AM